Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on June 2, 2025, for the month of June 2025. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically addresses the company's total voting rights and capital structure.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure and share counts rather than financial performance metrics.
Material Changes
The filing discloses the share capital status as of May 31, 2025. No material changes to financial performance or operational strategy are detailed in this specific document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves as a regulatory notification regarding share counts for disclosure obligations under the FCA's Disclosure Guidance and Transparency Rules.
Key Facts for Investors
- Total Issued Shares: As of May 31, 2025, Haleon has 9,005,330,185 ordinary shares of £0.01 each.
- Treasury Shares: 4,080,205 shares are held as treasury shares.
- Voting Rights: The number of ordinary shares with voting rights is 9,001,249,980.
- Disclosure Threshold: Shareholders must use the voting share count (9,001,249,980) as the denominator to calculate notifiable interests.
- Contact for Notifications: Notifiable interests should be sent to company.secretary@haleon.com.